Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $5 | $28 | $91 | $77 |
| - Cash | $18 | $29 | $23 | $18 |
| + Debt | $25 | $26 | $25 | $26 |
| Enterprise Value | $12 | $25 | $93 | $85 |
| Revenue | $48 | $37 | $30 | $34 |
| % Growth | 30.9% | 21.3% | -11.6% | – |
| Gross Profit | $10 | $2 | $7 | $12 |
| % Margin | 20.2% | 6.6% | 21.6% | 35% |
| EBITDA | -$15 | -$21 | -$19 | -$861 |
| % Margin | -30.2% | -57.1% | -63.2% | -2,498.3% |
| Net Income | -$23 | -$34 | -$26 | -$14 |
| % Margin | -48.2% | -91.8% | -83.8% | -39.7% |
| EPS Diluted | -0.96 | -1.4 | -1.34 | -0.81 |
| % Growth | 31.4% | -4.5% | -65.4% | – |
| Operating Cash Flow | -$13 | -$31 | -$19 | -$9 |
| Capital Expenditures | -$1 | -$2 | -$4 | -$4 |
| Free Cash Flow | -$14 | -$33 | -$23 | -$13 |